Restricted accessResearch articleFirst published online 2025-09
Structured Exercise Therapy Increases Endogenous Antioxidants to Repair Muscle Strength and Health in Porcine Ischemic Myopathy Model of Peripheral Artery Disease
The mechanisms of structured exercise therapy (SET) in peripheral artery disease (PAD) are not clear. We have developed an SET module for our large animal model of ischemic myopathy. We hypothesized that SET would increase muscle strength and walking distance in this model. The objective was to discover the SET-dependent mechanisms involved in this process.
Approach:
After induction of unilateral hind limb ischemia, three animals were exposed to standard environmental enrichment (sedentary or SED) and four animals underwent SET thrice weekly for 4 weeks postoperatively. Walking, hind limb pressure indices, and strength testing were performed weekly. Terminal muscle samples were used for skeletal muscle testing.
Results:
SET animals increased walking distance over time. SET increased muscle strength in both the ischemic and nonischemic limb. When comparing the ischemic SED hind limb muscle with that of ischemic + SET, the SET group has improved respiration and decreased oxidative stress. Markers of cell death and impaired functional regeneration were increased in SED ischemic muscles but returned toward baseline in the SET ischemic muscle.
Innovation:
This study uses a validated, large animal model of ischemic myopathy similar to that seen in humans with PAD. The effects of exercise on limb function, strength, and skeletal muscle health are reported in this model.
Conclusion:
SET increases muscle strength and regeneration by increasing endogenous antioxidants and mitochondrial respiration, resulting in favorable muscle health despite ongoing ischemia. This model may assist in preclinical testing of PAD therapies designed to improve muscle health.
Get full access to this article
View all access options for this article.
References
1.
ViraniSS, AlonsoA, AparicioHJ, et al;American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2021 Update: A report from the american heart association. Circulation, 2021; 143(8):e254–e743.
2.
PipinosII, JudgeAR, SelsbyJT, et al.The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type. Vasc Endovascular Surg, 2008; 42(2):101–112.
3.
PipinosII, JudgeAR, SelsbyJT, et al.The myopathy of peripheral arterial occlusive disease: Part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vasc Endovascular Surg, 2007; 41(6):481–489.
4.
CriquiMH, MatsushitaK, AboyansV, et al;American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council. Lower extremity peripheral artery disease: Contemporary epidemiology, management gaps, and future directions: A scientific statement from the american heart association. Circulation, 2021; 144(9):e171–e191.
5.
McDermottMM, DayanidhiS, KosmacK, et al.Walking exercise therapy effects on lower extremity skeletal muscle in peripheral artery disease. Circ Res, 2021; 128(12):1851–1867.
6.
BiswasMP, CapellWH, McDermottMM, et al.Exercise training and revascularization in the management of symptomatic peripheral artery disease. JACC Basic Transl Sci, 2021; 6(2):174–188.
7.
RahmanH, PipinosII, JohanningJM, et al.Claudicating patients with peripheral artery disease have meaningful improvement in walking speed after supervised exercise therapy. J Vasc Surg, 2021; 74(6):1987–1995.
8.
ParmenterBJ, DiebergG, PhippsG, et al.Exercise training for health-related quality of life in peripheral artery disease: A systematic review and meta-analysis. Vasc Med, 2015; 20(1):30–40.
9.
ParmenterBJ, DiebergG, SmartNA. Exercise training for management of peripheral arterial disease: A systematic review and meta-analysis. Sports Med, 2015; 45(2):231–244.
10.
GardnerAW, MontgomeryPS, ParkerDE. Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg, 2008; 47(1):117–122.
11.
LeeperNJ, MyersJ, ZhouM, et al.Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. J Vasc Surg, 2013; 57(3):728–733.
12.
McDermottMM, LiuK, FerrucciL, et al.Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Coll Cardiol, 2011; 57(8):962–970.
13.
JainA, LiuK, FerrucciL, et al.Declining walking impairment questionnaire scores are associated with subsequent increased mortality in peripheral artery disease. J Am Coll Cardiol, 2013; 61(17):1820–1829.
14.
McDermottMM, LiuK, TianL, et al.Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: A longitudinal study. J Am Coll Cardiol, 2012; 59(13):1159–1167.
15.
LongCA, TimminsLH, KoutakisP, et al.An endovascular model of ischemic myopathy from peripheral arterial disease. J Vasc Surg, 2017; 66(3):891–901.
16.
CoronaBT, CallJA, BorkowskiM, et al.In vivo measurement of hindlimb dorsiflexor isometric Torque from pig. J Vis Exp, 2021(175).
17.
HarwoodAE, KingS, TottyJ, et al.A systematic review of muscle morphology and function in intermittent claudication. J Vasc Surg, 2017; 66(4):1241–1257.
18.
Makrecka-KukaM, KrumschnabelG, GnaigerE. High-resolution respirometry for simultaneous measurement of oxygen and hydrogen peroxide fluxes in permeabilized cells, tissue homogenate and isolated Mitochondria. Biomolecules, 2015; 5(3):1319–1338.
19.
SmithPK, KrohnRI, HermansonGT, et al.Measurement of protein using bicinchoninic acid. Anal Biochem, 1985; 150(1):76–85.
20.
FletcherE, MiserlisD, SorokoletK, et al.Diet-induced obesity augments ischemic myopathy and functional decline in a murine model of peripheral artery disease. Translational Research, 2023; 260:17–31.
21.
AlomariE, BrunoS, RondaL, et al.Protein carbonylation detection methods: A comparison. Data Brief, 2018; 19:2215–2220.
22.
IsmaeelA, FletcherE, MiserlisD, et al.Skeletal muscle MiR-210 expression is associated with mitochondrial function in peripheral artery disease patients. Transl Res, 2022; 246:66–77.
23.
IsmaeelA, LaudatoJA, FletcherE, et al.High-fat diet augments the effect of alcohol on skeletal muscle mitochondrial dysfunction in mice. Nutrients, 2022; 14(5).
24.
MietusCJ, LacknerTJ, KarvelisPS, et al.Abnormal microvascular architecture, fibrosis, and pericyte characteristics in the calf muscle of peripheral artery disease patients with claudication and critical limb ischemia. J Clin Med, 2020; 9(8).
25.
ParkSY, PekasEJ, HeadidRJ3rd, et al.Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease. Am J Physiol Heart Circ Physiol, 2020; 319(2):H456–H467.
26.
KoutakisP, MiserlisD, MyersSA, et al.Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: Associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function. J Histochem Cytochem, 2015; 63(4):256–269.
27.
MitchellRG, DuschaBD, RobbinsJL, et al.Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease. Vasc Med, 2007; 12(4):285–290.
28.
RyanTE, YamaguchiDJ, SchmidtCA, et al.Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants. JCI Insight, 2018; 3(21).
29.
CalancaL, LanziS, NeyB, et al.Multimodal supervised exercise significantly improves walking performances without changing hemodynamic parameters in patients with symptomatic lower extremity peripheral artery disease. Vasc Endovascular Surg, 2020; 54(7):605–611.
30.
SpronkS, BoschJL, den HoedPT, et al.Intermittent claudication: Clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training–randomized controlled trial. Radiology, 2009; 250(2):586–595.
31.
JangYC, RodriguezK, LustgartenMS, et al.Superoxide-mediated oxidative stress accelerates skeletal muscle atrophy by synchronous activation of proteolytic systems. Geroscience, 2020; 42(6):1579–1591.
32.
JangYC, LustgartenMS, LiuY, et al.Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. Faseb J, 2010; 24(5):1376–1390.
33.
StevenS, DaiberA, DopheideJF, et al.Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects. Redox Biol, 2017; 12:787–797.
34.
KoutakisP, IsmaeelA, FarmerP, et al.Oxidative stress and antioxidant treatment in patients with peripheral artery disease. Physiol Rep, 2018; 6(7):e13650.
35.
IsmaeelA, BrumbergRS, KirkJS, et al.Oxidative stress and arterial dysfunction in peripheral artery disease. Antioxidants (Basel), 2018; 7(10).
36.
WeissDJ, CasaleGP, KoutakisP, et al.Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease. J Transl Med, 2013; 11:230.
37.
KoutakisP, WeissDJ, MiserlisD, et al.Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective. Redox Biol, 2014; 2:921–928.
38.
ShepardCR. TLR9 in MAFLD and NASH: At the intersection of inflammation and metabolism. Front Endocrinol, 2021; 11:613639.
39.
Rodriguez-NuevoA, Diaz-RamosA, NogueraE, et al.Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency. Embo J, 2018; 37(10).
40.
RileyJS, TaitSW. Mitochondrial DNA in inflammation and immunity. EMBO Rep, 2020; 21(4):e49799.
41.
CetlinMD, PolonskyT, HoK, et al.Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. J Vasc Surg, 2023; 77(2):506–514.
42.
HammondMM, TianL, ZhaoL, et al.Attendance at supervised exercise sessions and walking outcomes in peripheral artery disease: Results from 2 randomized clinical trials. J Am Heart Assoc, 2022; 11(24):e026136.
43.
HiattWR, WolfelEE, MeierRH, et al.Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation, 1994; 90(4):1866–1874.
44.
FokkenroodHJ, BendermacherBL, LauretGJ, et al.Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev, 2013; 23(8):CD005263.
45.
BradleyJM, IslamKN, PolhemusDJ, et al.Sustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease. Am J Physiol Heart Circ Physiol, 2015; 309(2):H305–H317.
46.
PolhemusDJ, BradleyJM, IslamKN, et al.Therapeutic potential of sustained-release sodium nitrite for critical limb ischemia in the setting of metabolic syndrome. Am J Physiol Heart Circ Physiol, 2015; 309(1):H82–H92.
47.
MehtaA, MavromatisK, KoYA, et al.Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study. Contemp Clin Trials, 2020; 91:105975.
48.
DeppenJN, GinnSC, TangEO, et al.Alginate-encapsulated mesenchymal stromal cells improve hind limb ischemia in a translational swine model. J Am Heart Assoc, 2024; 13(9):e029880.
49.
WangT, DongN, YanH, et al.Regeneration of a neoartery through a completely autologous acellular conduit in a minipig model: A pilot study. J Transl Med, 2019; 17(1):24.
50.
VenbruxA, GailloudP, RadvanyMG, et al.Acute, subacute, and long-term evaluation of a novel endovascular occlusion system in a large animal model. Catheter Cardiovasc Interv, 2015; 85(6):1026–1032.
51.
PabonM, ChengS, AltinSE, et al.Sex differences in peripheral artery disease. Circ Res, 2022; 130(4):496–511.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
